Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TENAX THERAPEUTICS, INC.TENX · Entity 979 | Director | June 10, 2021 | June 15, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TENAX THERAPEUTICS, INC.
Report date June 10, 2021 · Filed June 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2031-06-10 | Direct | 5,000 |
Reported balance
After 2021-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-10 · Grant · Acquired 5,000 · Balance 5,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 15, 2021 20:35 UTC | TENAX THERAPEUTICS, INC. TENX · Entity 979 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001654954-21-006929 · section16.xml · derivative · entry 1 Mitchum James P. · CIK 0001597439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2031-06-10 Read SEC document |
| May 01, 2020 Filed May 15, 2020 21:01 UTC | TENAX THERAPEUTICS, INC. TENX · Entity 979 | GrantStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001654954-20-005666 · section16.xml · derivative · entry 1 Mitchum James P. · CIK 0001597439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2030-05-01 Read SEC document |
| May 01, 2018 Filed Apr 18, 2019 20:31 UTC | TENAX THERAPEUTICS, INC. TENX · Entity 979 | GrantStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001654954-19-004583 · section16.xml · derivative · entry 1 Mitchum James P. · CIK 0001597439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2028-05-01 Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 16:31 UTC | TENAX THERAPEUTICS, INC. tenx · Entity 979 | Disposition to issuercommon stock | 7,000 | $1.51 | $10,570.00 |
DisclosureSEC source: 0001185945-16-000005 · primary_doc.xml · nonDerivative · entry 1 Mitchum James P. · CIK 0001597439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.